CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$433M
(+4.8%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
255
Reduced
393
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Robert Half
RHI
$3.77B
| $3.78M | 0.04% |
71,551
-57,124
| -44% | -$3.02M |
|
377
US Bancorp
USB
$75.9B
| $3.78M | 0.04% |
102,599
-25,235
| -20% | -$929K |
|
378
Agilent Technologies
A
$36.5B
| $3.75M | 0.04% |
42,472
-36,149
| -46% | -$3.19M |
|
379
Arcturus Therapeutics
ARCT
$485M
| $3.73M | 0.04% |
+79,720
| New | +$3.73M |
|
380
Atmos Energy
ATO
$26.7B
| $3.7M | 0.04% |
37,128
-9,376
| -20% | -$934K |
|
381
Veeva Systems
VEEV
$44.7B
| $3.61M | 0.04% |
15,416
-23,857
| -61% | -$5.59M |
|
382
EOG Resources
EOG
$64.4B
| $3.56M | 0.04% |
70,257
-6,078
| -8% | -$308K |
|
383
Rigel Pharmaceuticals
RIGL
$742M
| $3.56M | 0.04% |
194,300
-50,000
| -20% | -$915K |
|
384
Kinross Gold
KGC
$26.9B
| $3.54M | 0.04% |
492,143
-497,475
| -50% | -$3.58M |
|
385
Regions Financial
RF
$24.1B
| $3.52M | 0.04% |
316,594
-247,117
| -44% | -$2.75M |
|
386
Tandem Diabetes Care
TNDM
$850M
| $3.46M | 0.04% |
+35,000
| New | +$3.46M |
|
|
AYX
387
DELISTED
Alteryx, Inc.
AYX
| $3.42M | 0.04% |
+2,820
| New | +$3.42M |
|
388
Immunovant
IMVT
$2.99B
| $3.41M | 0.04% |
+140,000
| New | +$3.41M |
|
389
Travelers Companies
TRV
$62B
| $3.35M | 0.04% |
29,412
-8,483
| -22% | -$967K |
|
390
Sangamo Therapeutics
SGMO
$165M
| $3.32M | 0.04% |
370,000
-150,000
| -29% | -$1.34M |
|
391
Truist Financial
TFC
$60B
| $3.31M | 0.03% |
88,006
-46,082
| -34% | -$1.73M |
|
392
DaVita
DVA
$9.86B
| $3.3M | 0.03% |
41,698
+12,832
| +44% | +$1.02M |
|
393
Global Payments
GPN
$21.3B
| $3.3M | 0.03% |
19,446
-10,612
| -35% | -$1.8M |
|
394
Fiserv
FI
$73.4B
| $3.27M | 0.03% |
33,468
-8,417
| -20% | -$822K |
|
395
Marvell Technology
MRVL
$54.6B
| $3.22M | 0.03% |
91,926
-34,166
| -27% | -$1.2M |
|
396
Intercontinental Exchange
ICE
$99.8B
| $3.2M | 0.03% |
34,971
-14,194
| -29% | -$1.3M |
|
397
Carnival Corp
CCL
$42.8B
| $3.13M | 0.03% |
190,752
+131,155
| +220% | +$2.15M |
|
398
Kezar Life Sciences
KZR
$29.8M
| $3.11M | 0.03% |
+60,000
| New | +$3.11M |
|
399
FedEx
FDX
$53.7B
| $3.08M | 0.03% |
21,940
-8,055
| -27% | -$1.13M |
|
400
Infosys
INFY
$67.9B
| $3.07M | 0.03% |
318,207
-78,525
| -20% | -$759K |
|